Clinical outcomes and imaging characteristics of intra-arterial chemotherapy for retinoblastoma in Colombian children
Introduction Retinoblastoma is the most common malignant intraocular tumor in children, accounting for 10% to 15% of neoplasms diagnosed during the first year of life. Early diagnosis and multidisciplinary treatment have led to survival rates exceeding 95%, enabling ocular preservation. Intra-arterial chemotherapy (IAC) has transformed management by enhancing globe salvage while minimizing systemic toxicity. This study describes the clinical course, MRI findings, and outcomes of pediatric patients treated with IAC at two tertiary care institutions in Colombia. Materials and methods An analytical observational cohort study with retrospective data collection described a combined regional cohort of patients with intraocular retinoblastoma treated with IAC at two tertiary referral centers in Colombia (Fundación Valle del Lili [FVL] and Fundación Oftalmológica de Santander [FOSCAL]). All patients meeting inclusion criteria were enrolled, and data on demographics, imaging, treatment, complications, and outcomes were collected. As a secondary, exploratory analysis, categorical variables were compared between centers using Fisher's exact test and continuous variables using the Mann–Whitney U test; given the sample size, these comparisons should be interpreted as hypothesis-generating. The protocol was approved by the ethics committees of both institutions. Results Thirty-six patients (51 eyes) were included overall (median age at diagnosis: 1 year, IQR: 0–2; 61.11% female). Globe preservation was achieved in 47.22% of eyes, tumor regression in 52.78%, progression in 44.44%, and enucleation was required in 55.56%; overall mortality was 5.71%. In the secondary, exploratory comparison between centers, globe preservation (60.87% at FVL vs. 23.08% at FOSCAL; p = 0.041) and tumor progression (30.43% vs. 69.23%; p = 0.038) differed significantly, whereas enucleation did not ( p = 0.301); age at clinical presentation also differed significantly ( p = 0.032). Conclusions IAC was associated with meaningful globe preservation, although outcomes differed between centers, with lower vision preservation and higher tumor progression among patients presenting with more advanced disease. These exploratory findings underscore the importance of early detection, timely referral, and standardized IAC protocols to reduce inter-institutional disparities in retinoblastoma outcomes.
Authors
- Valentina Mejía‐Quiñones (ORCID: https://orcid.org/0000-0003-1908-3021)
- Oscar Eduardo García-Ledesma (ORCID: https://orcid.org/0000-0002-7370-4039)
- María Fernanda Estévez (ORCID: https://orcid.org/0000-0003-0851-7541)
- Juan Carlos Serrano (ORCID: https://orcid.org/0000-0002-3671-3809)
- Maria Alejandra Recio-Gómez (ORCID: https://orcid.org/0000-0002-1589-8138)
- C. Alejandro Luzardo Neira
- David Garay
- Daniel Eduardo Mantilla-García
Institutions
- Universidad Autónoma de Bucaramanga (CO)
- Fundación Valle del Lili (CO)
- Foscal Hospital (CO)
- Universidad Icesi (CO)
Publication Details
- Journal
- Frontiers in Radiology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fradi.2026.1878440
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00